Keywords
doping
college students
Abstract
Introduction. The non-medical use of prescription stimulants (NMUPS) has become of great interest for its diffusion among university students, engaged in NUMPS to cope with the increasing load of academic stress. This consumption has been more throughoutly investigated in the U.S. due to its increasing trend. However, NMUPS has been reported also in Europe. The aim of this cross-sectional study was to examine stimulants misuse in an Italian area, identifying possible developments of the phenomenon in Italy.
Methods.To evaluate academic and extra-academic NMUPS (Methylphenidate and Amphetamines), an anonymous multiple-choice questionnaire was administrated to a representative sample of Bachelor’s and Master’s degrees students attending a University of North of Italy.
Data elaboration and Confidence Interval 95% were performed with Excel software 2013, while Fisher's exact tests with GraphPad INSTAT software.
Results. Data from 899 correctly compiled questionnaires were analyzed in this study.
11.3% of students reported NMUPS with an apparent greater use by students aged 18-22 years (73.5%) and without any gender predominance (p: n.s.). 57,8% of students used stimulants at most five times in six months, while the most frequent academic and extra-academic motives for use were respectively to improve concentration while studying (51.0%) and sports performance (25.5%). NMUPS was higher among working students than non-working ones (p <0.05), suggesting a stimulants use to cope with stress by the first ones.
Conclusion. These data suggest that NMUPS is quite relevant in the North of Italy, requiring preventive and monitoring measures, besides future analysis with a longitudinal multicenter study.
References
Franke AG, Bagusat C, Rust S, Engel A, Lieb K. Substances used and prevalence rates of pharmacological cognitive enhancement among healthy subjects. Eur Arch Psychiatry Clin Neurosci. 2014; 264(1):S83-90. doi: 10.1007/s00406-014-0537-1.
Franke AG, Lieb K. Pharmacological neuroenhancement and brain doping: Chances and risks. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2010; 53(8):853-859. doi: 10.1007/s00103-010-1105-0.
Cakic V. Smart drugs for cognitive enhancement: ethical and pragmatic considerations in the era of cosmetic neurology. J Med Ethics. 2009; 35(10):611–615. doi:10.1136/jme.2009.030882.
Chatterjee A. Cosmetic neurology: For physicians the future is now. Virtual mentor. 2004; 6(8). doi:10.1001/virtualmentor.2004.6.8.oped1-0408.
Franke AG, Lieb K. Pharmacological neuroenhancement: substances and epidemiology. In Hildt E, Franke AG, editors. Cognitive enhancement-an interdisciplinary perspective. Springer; 2013. pp. 17–27.
Lucke JC, Bell SK, Partridge BJ, Hall WD. Academic doping or viagra for the brain? The history of recreational drug use and pharmacological enhancement can provide insight into these uses of neuropharmaceuticals. EMBO Rep. 2011; 12(3):197-201. doi:10.1038/embor.2011.15.
Muhammed K. Cosmetic neurology: the role of healthcare professionals. Med Health Care Philos. 2014; 17(2):239–240. doi:10.1007/s11019-013-9497-x.
Partridge BJ, Bell SK, Lucke JC, Yeates S, Hall WD. Smart drugs ‘‘as common as coffee’’: media hype about neuroenhancement. PLoS One. 2011; 6(11):1-2. doi:10.1371-journal.pone.0088416.
McCabe SE, Teter CJ, Boyd CJ. Medical use, illicit use and diversion of prescription stimulant medication. J Psychoactive Drugs. 2006; 38(1):43–56. doi:10.3200/JACH.54.5.269-272.
McCabe SE, Knight JR, Teter CJ, Wechsler H. Non- medical use of prescription stimulants among us college students: prevalence and correlates from a national survey. Addiction. 2005; 100(1):96–106. doi:10.1111/j.1360-0443.2005.00944.x.
Carter CA, Kahnweiler WM. The efficacy of the social norms approach to substance abuse prevention applied to fraternity men. J Am Coll Health. 2000; 49(2):66-71. doi:10.1080/07448480009596286.
Maher B. Poll results: look who’s doping. Nature. 2008; 452(7188): 674–675. doi:10.1038/452674a.
Anderson M, Ronning E, De Vries R, Martinson B. The perverse effects of competition on scientists’ work and relationships. Science and Engineering Ethics. 2007; 13(4): 437–461. doi:10.1007/s11948-007-9042-5.
Betancourt J, Ríos JL, Pagán I, Fabián C, González AM, Cruz SY, González MJ, Rivera WT, Palacios C. Non-medical use of prescription drugs and its association with socio-demographic characteristics, dietary pattern, and perceived academic load and stress in college students in Puerto Rico. P R Health Sci J. 2013; 32(2):89-94.
Wilens TE, Adler LA, Adams J, Sgambati S, Rotrosen J, Sawtelle R, Utzinger L, Fusillo S. Misuse and diversion of stimulants prescribes for ADHD: a systematic review of the literature. Journal of the American Academy of Child and Adolescent Psychiatry. 2008; 47(1): 21–31. doi:10.1097/chi.0b013e31815a56f1.
Bavarian N1, Flay BR, Ketcham PL, Smit E. Illicit use of prescription stimulants in a college student sample: a theory-guided analysis. Drug Alcohol Depend. 2013;132(3):665-73. doi: 10.1016/j.drugalcdep.2013.04.024.
Teter CJ, McCabe SE, LaGrange K, Cranford JA, Boyd CJ. Illicit use of specific prescription stimulants among college students: prevalence, motives, and routes of administration. Pharmacotherapy. 2006; 26(10):1501–1510. doi:10.1592/phco.26.10.1501.
McCabe SE, Boyd CJ. Sources of prescription drugs for illicit use. Addict Behav. 2005; 30(7):1342–1350. doi:10.1016/j.addbeh.2005.01.012.
Teter CJ, Falone AE, Cranford JA, Boyd CJ, McCabe SE. Nonmedical use of prescription stimulants and depressed mood among college students: frequency and routes of administration. J Subst Abuse Treat. 2010; 38(3):292–298. doi:10.1016/j.jsat.2010.01.005.
Franke AG, Bonertz C, Christmann M, Huss M, Fellgiebel A, Hildt E, Lieb K. Non-medical use of prescription stimulants and illicit use of stimulants for cognitive enhancement in pupils and students in Germany. Pharmacopsychiatry. 2011;44(2):60-6. doi: 10.1055/s-0030-1268417.
Ott R, Biller-Andorno N. Neuroenhancement among swiss students–a comparison of users and non-users. Pharmacopsychiatry. 2014; 47(1):22–28. doi:10.1055/s-0033-1358682.
Jeffers AJ, Benotsch EG. Non-medical use of prescription stimulants for weight loss, disordered eating, and body image. Eat Behav. 2014;15(3):414-418. doi: 10.1016/j.eatbeh.2014.04.019.
Freese L, Signor L, Machado C, Ferigolo M, Tannhauser Barros H M. Non-medical use of methylphenidate: a review. Trends Psychiatry Psychother. 2012;34(2):110-115.
http://dx.doi.org/10.151590/S2237-60892012000200010.
Klein-Schwartz W, McGrath J. Poison centers' experience with methylphenidate abuse in pre-teens and adolescents. J Am Acad Child Adolesc Psychiatry. 2003;42(3):288-294. doi:10.1097/00004583-200303000-00008.
Fitzgerald KT, Bronstein AC. Adderall® (amphetamine-dextroamphetamine) toxicity. Top Companion Anim Med. 2013;28(1):2-7. doi: 10.1053/j.tcam.2013.03.002.
McCabe SE. Screening for Drug Abuse Among Medical and Nonmedical Users of Prescription Drugs in a Probability Sample of College Students. Arch Pediatr Adolesc Med 2008;162(3):225-231. doi:10.1001/archpediatrics.2007.41.
Johnston LD, O’Malley PM, Bachman JG, Schulenberg JE. Monitoring the Future national survey results on drug use, 1975–2004. College students and adults Ages 19–45. Available at:
http://files.eric.ed.gov/fulltext/ED489469.pdf
Accessed on March 2016.
Ghandour LA, El Sayed DS, Martins SS. Prevalence and patterns of commonly abused psychoactive prescription drugs in a sample of university students from Lebanon: An opportunity for cross-cultural comparisons. Drug Alcohol Depend. 2012; 121(1-2):110-117. doi:10.1016/j.drugalcdep.2011.08.021.
Sattler S, Wiegel C. Cognitive test anxiety and cognitive enhancement: the influence of students' worries on their use of performance-enhancing drugs. Subst Use Misuse. 2013;48(3):220-32. doi: 10.3109/10826084.2012.751426.
Charitonidi E, Studer J, Gaume J, Gmel G, Daeppen JB, Bertholet N. Socioeconomic status and substance use among Swiss young men: a population-based cross-sectional study. BMC Public Health. 2016;16(1):333. doi: 10.1186/s12889-016-2949-5.
Barrett SP, Darredeau C, Pihl RO. Patterns of simultaneous polysubstance use in drug using university students. Hum Psychopharmacol. 2006 ;21(4):255-63. doi: 10.1002/hup.766
Arce M, Brunet K, Jimenez A, Mansilla P, Sheplan P, Vanoni A, Yulfo Y, Zayas R, Zierenberg C. El uso de estimulantes con o sin receta para el aprovechamiento académico entre estudiantes de Medicina en Puerto Rico. Rev Puerto Med Salud Pública 2011;26:24-33.
Sinha R. How does stress increase risk of drug abuse and relapse? Psychopharmacology (Berl). 2001;158(4):343-359. doi:10.1007/s002130100917.
Aselton P. Sources of Stress and Coping in American College Students Who Have Been Diagnosed With Depressionj Journal of Child and Adolescent Psychiatric nursing. 2012; 25(3):119-23. doi: 10.1111/j.1744-6171.2012.00341.x.
Inglis SK, Carucci S, Garas P, Häge A, Banaschewski T, Buitelaar JK, Dittmann RW, Falissard B, Hollis C, Kovshoff H, Liddle E, McCarthy S, Nagy P, Neubert A, Rosenthal E, Sonuga-Barke E, Wong I, Zuddas A, Coghill DC; ADDUCE Consortium. Prospective observational study protocol to investigate long-term adverse effects of methylphenidate in children and adolescents with ADHD: The Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects (ADDUCE) study. BMJ Open. 2016; 6(4):e010433. doi:10.1136/bmjopen-2015- 010433.
Substance Abuse and Mental Health Services Administration. Emergency department visits involving attention deficit/hyperactivity disorder stimulant mediations. Available at: http://www.samhsa.gov/data/2k13/DAWN073/sr073-ADD-ADHD-medications.htm
Accessed on March 2016.
Ciccarone D. Stimulant abuse: pharmacology, cocaine, methamphetamine, treatment, attempts at pharmacotherapy. Prim. Care. 2011; 38(1):41-58, v–vi. doi:10.1016/j.pop.2010.11.004
Leibson CL, Katusic SK, Barbaresi WJ, Ransom J, O’Brien PC. Use and costs of medical care for children and adolescents with and without attention-deficit/hyperactivity disorder. JAMA. 2001; 285(1): 60–66.doi:10.1001/jama.285.1.60.
Goldman LS, Bexman RJ, Slanetz PJ. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. JAMA 1998;279(14):1100–1107. doi:10.1001/jama.279.14.1100.